+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
gRNA Market Size, Share & Trends Analysis Report by Product & Service (Products, Custom gRNA Synthesis Services), gRNA Type (Research-use, GPM-grade), Application, End-use, and Region with Growth Forecasts, 2025-2033- Product Image
gRNA Market Size, Share & Trends Analysis Report by Product & Service (Products, Custom gRNA Synthesis Services), gRNA Type (Research-use, GPM-grade), Application, End-use, and Region with Growth Forecasts, 2025-2033- Product Image
New

gRNA Market Size, Share & Trends Analysis Report by Product & Service (Products, Custom gRNA Synthesis Services), gRNA Type (Research-use, GPM-grade), Application, End-use, and Region with Growth Forecasts, 2025-2033

  • PDF Icon

    Report

  • 150 Pages
  • December 2025
  • Region: Global
  • Grand View Research
  • ID: 5936583
REQUEST CUSTOMIZATION
Description Jump to:
The global gRNA market size was estimated at USD 579.5 million in 2024 and is projected to reach USD 2.66 billion by 2033, growing at a CAGR of 18.64% from 2025 to 2033. gRNA is in high demand because it is essential for CRISPR-based genetic editing.

Its ability to accurately guide the CRISPR system to specific DNA sequences enables precise gene modifications, driving breakthroughs in medicine, agriculture, and biotechnology.

Expansion of CRISPR Gene Editing Applications

The global demand for gRNA is rising sharply due to the rapid expansion of CRISPR applications across research and industry. As the critical element that directs CRISPR to specific DNA or RNA targets, every CRISPR workflow depends on precise and reliable gRNA. Increasing use of CRISPR in functional genomics, knockout/knock-in studies, engineered cell models, and high-throughput screening has driven strong growth in customized gRNA consumption. With CRISPR advancing from research to clinical and therapeutic applications, especially in gene therapy and precision medicine, more biopharma and academic labs are adopting the technology, further escalating the need for specialized gRNA. For instance, in October 2021, in Germany, Merck licensed its patented CRISPR-Cas9 technology to Cellecta, enabling advanced knock-in applications.

The growing diversification of CRISPR systems is further boosting demand for tailored gRNA products. As gene-editing advances from traditional Cas9 to next-generation tools like Cas12 and Cas13 for RNA targeting, for compact delivery, and platforms such as base and prime editing, researchers require highly optimized gRNAs with greater efficiency and minimal off-target effects.

Global gRNA Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. The report has segmented the global gRNA market report based on product & services, gRNA type, application, end-use, and region:
  • Product & Service Outlook (Revenue in USD Million, 2021-2033)
  • Products
  • Custom gRNA Synthesis Services

gRNA Type Outlook (Revenue, USD Million, 2021-2033)

  • Research-Use
  • GMP-grade

Application Outlook (Revenue, USD Million; 2021-2033)

  • Genome Engineering
  • Disease Model Studies
  • Functional Genomics
  • Epigenetics
  • Others

End-use Outlook (Revenue, USD Million; 2021-2033)

  • Pharmaceutical & Biotechnology Companies
  • Academic Research Institutes
  • CMOs & CROs

Regional Outlook (Revenue, USD Million, 2021-2033)

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa

Why You Should Buy This Report

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Product & Service
1.2.2. gRNA Type
1.2.3. Application
1.2.4. End Use
1.3. Information analysis
1.4. Market formulation & data visualization
1.5. Data validation & publishing
1.6. Information Procurement
1.6.1. Primary Research
1.7. Information or Data Analysis
1.8. Market Formulation & Validation
1.9. Market Model
1.10. Objectives
1.10.1. Objective 1
1.10.2. Objective 2
Chapter 2. gRNA Market: Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. gRNA Market Variables and Trends
3.1. Market Segmentation and Scope
3.2. Market Lineage Outlook
3.2.1. Parent Market Outlook
3.2.2. Related/Ancillary Market Outlook
3.3. Market Dynamics
3.4. Market Drivers Analysis
3.4.1. Expansion of CRISPR gene editing applications
3.4.2. Growing R&D in proteomics and genomics
3.5. Market Restraint Analysis
3.5.1. Regulatory Challenges
3.5.2. Off-Target Effects and Safety Concerns
3.6. Business Environment Analysis
3.6.1. Porter’s Five Forces Analysis
3.6.2. PESTLE Analysis
Chapter 4. Product & Service Estimates & Trend Analysis
4.1. Product & Service Segment Dashboard
4.2. gRNA market: Product & Service Movement Analysis
4.3. Products
4.3.1. Products Market Estimates and Forecasts, 2021-2033 (USD Million)
4.3.2. gRNA Final Products
4.3.2.1. gRNA Final Products Market Estimates and Forecasts, 2021-2033 (USD Million)
4.3.3. gRNA Synthesis Products
4.3.3.1. gRNA Synthesis Products Market Estimates and Forecasts, 2021-2033 (USD Million)
4.3.3.2. gRNA Synthesis Kits
4.3.3.2.1. gRNA Synthesis Kits Market Estimates and Forecasts, 2021-2033 (USD Million)
4.3.3.3. Plasmids
4.3.3.3.1. Plasmids Market Estimates and Forecasts, 2021-2033 (USD Million)
4.3.3.4. Others
4.3.3.4.1. Others Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4. Custom gRNA Synthesis Services
4.4.1. Custom gRNA Synthesis Services Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 5. gRNA Type Estimates & Trend Analysis
5.1. gRNA Type Segment Dashboard
5.2. gRNA market: gRNA Type Movement Analysis
5.3. Research-Use
5.3.1. Research-Use Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.4. GMP-grade
5.4.1. GMP-grade Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 6. Application Estimates & Trend Analysis
6.1. Application Segment Dashboard
6.2. gRNA market: Application Movement Analysis
6.3. Genome Engineering
6.3.1. Genome Engineering Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
6.4. Disease Model Studies
6.4.1. Disease Model Studies Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
6.5. Functional Genomics
6.5.1. Functional Genomics Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
6.6. Epigenetics
6.6.1. Epigenetics Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
6.7. Others
6.7.1. Others Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 7. End Use Estimates & Trend Analysis
7.1. End Use Segment Dashboard
7.2. gRNA market: End-Use Movement Analysis
7.3. Pharmaceutical & Biotechnology Companies
7.3.1. Pharmaceutical & Biotechnology Companies Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
7.4. Academic Research Institutes
7.4.1. Academic Research Institutes Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
7.5. CMOs & CROs
7.5.1. CMOs & CROs Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 8. Regional Business Analysis
8.1. Regional Market Share Analysis, 2024 & 2033
8.2. Regional Market Dashboard
8.3. Market Size & Forecasts Trend Analysis, 2021 to 2033
8.4. North America
8.4.1. North America gRNA Market Estimates And Forecast, 2021-2033 (USD Million)
8.4.2. U.S.
8.4.2.1. Key Country Dynamics
8.4.2.2. Competitive Scenario
8.4.2.3. Regulatory Framework
8.4.2.4. Target Disease Prevalence
8.4.2.5. U.S. gRNA Market, 2021-2033 (USD Million)
8.4.3. Canada
8.4.3.1. Key Country Dynamics
8.4.3.2. Competitive Scenario
8.4.3.3. Regulatory Framework
8.4.3.4. Target Disease Prevalence
8.4.3.5. Canada gRNA Market, 2021-2033 (USD Million)
8.4.4. Mexico
8.4.4.1. Key Country Dynamics
8.4.4.2. Competitive Scenario
8.4.4.3. Regulatory Framework
8.4.4.4. Target Disease Prevalence
8.4.4.5. Mexico gRNA Market, 2021-2033 (USD Million)
8.5. Europe
8.5.1. Europe gRNA Market, 2021-2033 (USD Million)
8.5.2. UK
8.5.2.1. Key Country Dynamics
8.5.2.2. Competitive Scenario
8.5.2.3. Regulatory Framework
8.5.2.4. Target Disease Prevalence
8.5.2.5. UK gRNA Market, 2021-2033 (USD Million)
8.5.3. Germany
8.5.3.1. Key Country Dynamics
8.5.3.2. Competitive Scenario
8.5.3.3. Regulatory Framework
8.5.3.4. Target Disease Prevalence
8.5.3.5. Germany gRNA Market, 2021-2033 (USD Million)
8.5.4. Spain
8.5.4.1. Key Country Dynamics
8.5.4.2. Competitive Scenario
8.5.4.3. Regulatory Framework
8.5.4.4. Target Disease Prevalence
8.5.4.5. Spain gRNA Market, 2021-2033 (USD Million)
8.5.5. France
8.5.5.1. Key Country Dynamics
8.5.5.2. Competitive Scenario
8.5.5.3. Regulatory Framework
8.5.5.4. Target Disease Prevalence
8.5.5.5. France gRNA Market, 2021-2033 (USD Million)
8.5.6. Italy
8.5.6.1. Key Country Dynamics
8.5.6.2. Competitive Scenario
8.5.6.3. Regulatory Framework
8.5.6.4. Target Disease Prevalence
8.5.6.5. Italy gRNA Market, 2021-2033 (USD Million)
8.5.7. Denmark
8.5.7.1. Key Country Dynamics
8.5.7.2. Competitive Scenario
8.5.7.3. Regulatory Framework
8.5.7.4. Target Disease Prevalence
8.5.7.5. Denmark gRNA Market, 2021-2033 (USD Million)
8.5.8. Sweden
8.5.8.1. Key Country Dynamics
8.5.8.2. Competitive Scenario
8.5.8.3. Regulatory Framework
8.5.8.4. Target Disease Prevalence
8.5.8.5. Sweden gRNA Market, 2021-2033 (USD Million)
8.5.9. Norway
8.5.9.1. Key Country Dynamics
8.5.9.2. Competitive Scenario
8.5.9.3. Regulatory Framework
8.5.9.4. Target Disease Prevalence
8.5.9.5. Norway gRNA Market, 2021-2033 (USD Million)
8.6. Asia-Pacific
8.6.1. Asia-Pacific gRNA Market, 2021-2033 (USD Million)
8.6.2. Japan
8.6.2.1. Key Country Dynamics
8.6.2.2. Competitive Scenario
8.6.2.3. Regulatory Framework
8.6.2.4. Target Disease Prevalence
8.6.2.5. Japan gRNA Market, 2021-2033 (USD Million)
8.6.3. China
8.6.3.1. Key Country Dynamics
8.6.3.2. Competitive Scenario
8.6.3.3. Regulatory Framework
8.6.3.4. Target Disease Prevalence
8.6.3.5. China gRNA Market, 2021-2033 (USD Million)
8.6.4. India
8.6.4.1. Key Country Dynamics
8.6.4.2. Competitive Scenario
8.6.4.3. Regulatory Framework
8.6.4.4. Target Disease Prevalence
8.6.4.5. India gRNA Market, 2021-2033 (USD Million)
8.6.5. South Korea
8.6.5.1. Key Country Dynamics
8.6.5.2. Competitive Scenario
8.6.5.3. Regulatory Framework
8.6.5.4. Target Disease Prevalence
8.6.5.5. South Korea gRNA Market, 2021-2033 (USD Million)
8.6.6. Thailand
8.6.6.1. Key Country Dynamics
8.6.6.2. Competitive Scenario
8.6.6.3. Regulatory Framework
8.6.6.4. Target Disease Prevalence
8.6.6.5. Thailand gRNA Market, 2021-2033 (USD Million)
8.6.7. Australia
8.6.7.1. Key Country Dynamics
8.6.7.2. Competitive Scenario
8.6.7.3. Regulatory Framework
8.6.7.4. Target Disease Prevalence
8.6.7.5. Australia gRNA Market, 2021-2033 (USD Million)
8.7. Latin America
8.7.1. Latin America gRNA Market, 2021-2033 (USD Million)
8.7.2. Brazil
8.7.2.1. Key Country Dynamics
8.7.2.2. Competitive Scenario
8.7.2.3. Regulatory Framework
8.7.2.4. Target Disease Prevalence
8.7.2.5. Brazil gRNA Market, 2021-2033 (USD Million)
8.7.3. Argentina
8.7.3.1. Key Country Dynamics
8.7.3.2. Competitive Scenario
8.7.3.3. Regulatory Framework
8.7.3.4. Target Disease Prevalence
8.7.3.5. Argentina gRNA Market, 2021-2033 (USD Million)
8.8. MEA
8.8.1. MEA gRNA Market, 2021-2033 (USD Million)
8.8.2. South Africa
8.8.2.1. Key Country Dynamics
8.8.2.2. Competitive Scenario
8.8.2.3. Regulatory Framework
8.8.2.4. Target Disease Prevalence
8.8.2.5. South Africa gRNA Market, 2021-2033 (USD Million)
8.8.3. Saudi Arabia
8.8.3.1. Key Country Dynamics
8.8.3.2. Competitive Scenario
8.8.3.3. Regulatory Framework
8.8.3.4. Target Disease Prevalence
8.8.3.5. Saudi Arabia gRNA Market, 2021-2033 (USD Million)
8.8.4. UAE
8.8.4.1. Key Country Dynamics
8.8.4.2. Competitive Scenario
8.8.4.3. Regulatory Framework
8.8.4.4. Target Disease Prevalence
8.8.4.5. UAE gRNA Market, 2021-2033 (USD Million)
8.8.5. Kuwait
8.8.5.1. Key Country Dynamics
8.8.5.2. Competitive Scenario
8.8.5.3. Regulatory Framework
8.8.5.4. Target Disease Prevalence
8.8.5.5. Kuwait gRNA Market, 2021-2033 (USD Million)
Chapter 9. Competitive Landscape
9.1. Company Categorization
9.2. Strategy Mapping
9.3. Market Position Analysis, 2024
9.4. Company Profiles
9.4.1. Thermo Fisher Scientific, Inc
9.4.1.1. Company Overview
9.4.1.2. Financial Performance
9.4.1.3. Product Benchmarking
9.4.1.4. Strategic Initiatives
9.4.2. Agilent Technologies, Inc.
9.4.2.1. Company Overview
9.4.2.2. Financial Performance
9.4.2.3. Product Benchmarking
9.4.2.4. Strategic Initiatives
9.4.3. System Biosciences, LLC.
9.4.3.1. Company Overview
9.4.3.2. Financial Performance
9.4.3.3. Product Benchmarking
9.4.3.4. Strategic Initiatives
9.4.4. Jena Bioscience GmbH
9.4.4.1. Company Overview
9.4.4.2. Financial Performance
9.4.4.3. Product Benchmarking
9.4.4.4. Strategic Initiatives
9.4.5. Merck KGaA
9.4.5.1. Company Overview
9.4.5.2. Financial Performance
9.4.5.3. Product Benchmarking
9.4.5.4. Strategic Initiatives
9.4.6. Azenta Life Sciences (Genewiz)
9.4.6.1. Company Overview
9.4.6.2. Product Benchmarking
9.4.6.3. Strategic Initiatives
9.4.7. Takara Bio Inc.
9.4.7.1. Company Overview
9.4.7.2. Financial Performance
9.4.7.3. Product Benchmarking
9.4.7.4. Strategic Initiatives
9.4.8. Synbio Technologies
9.4.8.1. Company Overview
9.4.8.2. Financial Performance
9.4.8.3. Product Benchmarking
9.4.8.4. Strategic Initiatives
9.4.9. Revvity Inc (Horizon Discovery Ltd.)
9.4.9.1. Company Overview
9.4.9.2. Financial Performance
9.4.9.3. Product Benchmarking
9.4.9.4. Strategic Initiatives
9.4.10. Synthego
9.4.10.1. Company Overview
9.4.10.2. Financial Performance
9.4.10.3. Product Benchmarking
9.4.10.4. Strategic Initiatives
List of Tables
TABLE 1 Market Research Process
TABLE 2 Information Procurement
TABLE 3 Primary Research Pattern
TABLE 4 Market Research Approaches
TABLE 5 Value Chain-Based Sizing & Forecasting
TABLE 6 Market Formulation & Validation
TABLE 7 gRNA market Segmentation
TABLE 8 Market Snapshot, 2024
TABLE 9 Market Trends & Outlook
TABLE 10 Market Driver Relevance Analysis (Current & Future Impact)
TABLE 11 Market Restraint Relevance Analysis (Current & Future Impact)
TABLE 12 SWOT Analysis, by Factor (Political & Legal, Economic, And Technological)
TABLE 13 Porter’s Five Forces Analysis
TABLE 14 Global gRNA market: Product & Service Movement Analysis
TABLE 15 Global gRNA market, for Products, 2021-2033 (USD Million)
TABLE 16 Global gRNA market, for gRNA Final Products, 2021-2033 (USD Million)
TABLE 17 Global gRNA market, for gRNA Synthesis Products, 2021-2033 (USD Million)
TABLE 18 Global gRNA market, for gRNA Synthesis Kits, 2021-2033 (USD Million)
TABLE 19 Global gRNA market, for Plasmids, 2021-2033 (USD Million)
TABLE 20 Global gRNA market, for Others, 2021-2033 (USD Million)
TABLE 21 Global gRNA market, for Custom gRNA Synthesis Services, 2021-2033 (USD Million)
TABLE 22 Global gRNA market: gRNA Type Movement Analysis
TABLE 23 Global gRNA market, for Research-Use, 2021-2033 (USD Million)
TABLE 24 Global gRNA market, for GMP-grade, 2021-2033 (USD Million)
TABLE 25 Global gRNA market: Application Movement Analysis
TABLE 26 Global gRNA market, for Genome Engineering, 2021-2033 (USD Million)
TABLE 27 Global gRNA market, for Disease Model Studies, 2021-2033 (USD Million)
TABLE 28 Global gRNA market, for Functional Genomics, 2021-2033 (USD Million)
TABLE 29 Global gRNA market, for Epigenetics, 2021-2033 (USD Million)
TABLE 30 Global gRNA market, for Others, 2021-2033 (USD Million)
TABLE 31 Global gRNA market: End Use Movement Analysis
TABLE 32 Global gRNA market, for Pharmaceutical & Biotechnology Companies, 2021-2033 (USD Million)
TABLE 33 Global gRNA market, for Academic Research Institutes, 2021-2033 (USD Million)
TABLE 34 Global gRNA market, for CMOs & CROs, 2021-2033 (USD Million)
TABLE 35 Regional Marketplace: Key Takeaways
TABLE 36 Regional Outlook, 2023 & 2033
TABLE 37 Global gRNA market: Region Movement Analysis
TABLE 38 North America gRNA market, 2021-2033 (USD Million)
TABLE 39 U.S. gRNA market, 2021-2033 (USD Million)
TABLE 40 Canada gRNA market, 2021-2033 (USD Million)
TABLE 41 Mexico gRNA market, 2021-2033 (USD Million)
TABLE 42 Europe gRNA market, 2021-2033 (USD Million)
TABLE 43 Germany gRNA market, 2021-2033 (USD Million)
TABLE 44 UK gRNA market, 2021-2033 (USD Million)
TABLE 45 France gRNA market, 2021-2033 (USD Million)
TABLE 46 Italy gRNA market, 2021-2033 (USD Million)
TABLE 47 Spain gRNA market, 2021-2033 (USD Million)
TABLE 48 Denmark gRNA market, 2021-2033 (USD Million)
TABLE 49 Sweden gRNA market, 2021-2033 (USD Million)
TABLE 50 Norway gRNA market, 2021-2033 (USD Million)
TABLE 51 Asia-Pacific gRNA market, 2021-2033 (USD Million)
TABLE 52 Japan gRNA market, 2021-2033 (USD Million)
TABLE 53 China gRNA market, 2021-2033 (USD Million)
TABLE 54 India gRNA market, 2021-2033 (USD Million)
TABLE 55 Australia gRNA market, 2021-2033 (USD Million)
TABLE 56 South Korea gRNA market, 2021-2033 (USD Million)
TABLE 57 Thailand gRNA market, 2021-2033 (USD Million)
TABLE 58 Latin America gRNA market, 2021-2033 (USD Million)
TABLE 59 Brazil gRNA market, 2021-2033 (USD Million)
TABLE 60 Argentina gRNA market, 2021-2033 (USD Million)
TABLE 61 Middle East and Africa gRNA market, 2021-2033 (USD Million)
TABLE 62 South Africa gRNA market, 2021-2033 (USD Million)
TABLE 63 Saudi Arabia gRNA market, 2021-2033 (USD Million)
TABLE 64 UAE gRNA market, 2021-2033 (USD Million)
TABLE 65 Kuwait gRNA market, 2021-2033 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Data triangulation techniques
Figure 3 Market formulation & validation
Figure 4 gRNA market: Market outlook
Figure 5 gRNA market: Segment outlook
Figure 6 gRNA market: Competitive landscape outlook
Figure 7 Parent market outlook
Figure 8 gRNA market driver impact
Figure 9 gRNA market restraint impact
Figure 10 gRNA market: Product & Service outlook and key takeaways
Figure 11 gRNA market: Product & Service movement analysis
Figure 12 Products market estimates and forecasts, 2021-2033 (USD Million)
Figure 13 gRNA Final Products market estimates and forecasts, 2021-2033 (USD Million)
Figure 14 gRNA Synthesis Products market estimates and forecasts, 2021-2033 (USD Million)
Figure 15 gRNA Synthesis Kits market estimates and forecasts, 2021-2033 (USD Million)
Figure 16 Plasmids market estimates and forecasts, 2021-2033 (USD Million)
Figure 17 Others market estimates and forecasts, 2021-2033 (USD Million)
Figure 18 Custom gRNA Synthesis Services market estimates and forecasts, 2021-2033 (USD Million)
Figure 19 gRNA market: gRNA Type outlook and key takeaways
Figure 20 gRNA market: gRNA Type movement analysis
Figure 21 Research-Use market estimates and forecasts, 2021-2033 (USD Million)
Figure 22 GMP-grade market estimates and forecasts, 2021-2033 (USD Million)
Figure 23 gRNA market: Application outlook and key takeaways
Figure 24 gRNA market: Application movement analysis
Figure 25 Genome Engineering market estimates and forecasts, 2021-2033 (USD Million)
Figure 26 Disease Model Studies market estimates and forecasts, 2021-2033 (USD Million)
Figure 27 Functional Genomics market estimates and forecasts, 2021-2033 (USD Million)
Figure 28 Epigenetics market estimates and forecasts, 2021-2033 (USD Million)
Figure 29 Others market estimates and forecasts, 2021-2033 (USD Million)
Figure 30 gRNA market: End use outlook and key takeaways
Figure 31 gRNA market: End use movement analysis
Figure 32 Academic & research institutes market estimates and forecasts, 2021-2033 (USD Million)
Figure 33 Pharmaceutical & biotechnology companies market estimates and forecasts,2021-2033 (USD Million)
Figure 34 CMOs & CROs market estimates and forecasts,2021-2033 (USD Million)
Figure 35 Global gRNA market: Regional outlook and key takeaways
Figure 36 Global gRNA market: Regional movement analysis
Figure 37 North America market estimates and forecasts, 2021-2033 (USD Million)
Figure 38 Key country dynamics
Figure 39 U.S. market estimates and forecasts, 2021-2033 (USD Million)
Figure 40 Key country dynamics
Figure 41 Canada market estimates and forecasts, 2021-2033 (USD Million)
Figure 42 Key country dynamics
Figure 43 Mexico market estimates and forecasts, 2021-2033 (USD Million)
Figure 44 Europe market estimates and forecasts, 2021-2033 (USD Million)
Figure 45 Key country dynamics
Figure 46 UK market estimates and forecasts, 2021-2033 (USD Million)
Figure 47 Key country dynamics
Figure 48 Germany market estimates and forecasts, 2021-2033 (USD Million)
Figure 49 Key country dynamics
Figure 50 France market estimates and forecasts, 2021-2033 (USD Million)
Figure 51 Key country dynamics
Figure 52 Italy market estimates and forecasts, 2021-2033 (USD Million)
Figure 53 Key country dynamics
Figure 54 Spain market estimates and forecasts, 2021-2033 (USD Million)
Figure 55 Key country dynamics
Figure 56 Denmark market estimates and forecasts, 2021-2033 (USD Million)
Figure 57 Key country dynamics
Figure 58 Sweden market estimates and forecasts, 2021-2033 (USD Million)
Figure 59 Key country dynamics
Figure 60 Norway market estimates and forecasts, 2021-2033 (USD Million)
Figure 61 Asia-Pacific market estimates and forecasts, 2021-2033 (USD Million)
Figure 62 Key country dynamics
Figure 63 China market estimates and forecasts, 2021-2033 (USD Million)
Figure 64 Key country dynamics
Figure 65 Japan market estimates and forecasts, 2021-2033 (USD Million)
Figure 66 Key country dynamics
Figure 67 India market estimates and forecasts, 2021-2033 (USD Million)
Figure 68 Key country dynamics
Figure 69 Thailand market estimates and forecasts, 2021-2033 (USD Million)
Figure 70 Key country dynamics
Figure 71 South Korea market estimates and forecasts, 2021-2033 (USD Million)
Figure 72 Key country dynamics
Figure 73 Australia market estimates and forecasts, 2021-2033 (USD Million)
Figure 74 Latin America market estimates and forecasts, 2021-2033 (USD Million)
Figure 75 Key country dynamics
Figure 76 Brazil market estimates and forecasts, 2021-2033 (USD Million)
Figure 77 Key country dynamics
Figure 78 Argentina market estimates and forecasts, 2021-2033 (USD Million)
Figure 79 Middle East and Africa market estimates and forecasts, 2021-2033 (USD Million)
Figure 80 Key country dynamics
Figure 81 South Africa market estimates and forecasts, 2021-2033 (USD Million)
Figure 82 Key country dynamics
Figure 83 Saudi Arabia market estimates and forecasts, 2021-2033 (USD Million)
Figure 84 Key country dynamics
Figure 85 UAE market estimates and forecasts, 2021-2033 (USD Million)
Figure 86 Key country dynamics
Figure 87 Kuwait market estimates and forecasts, 2021-2033 (USD Million)

Companies Mentioned

The companies profiled in this gRNA market report include:
  • Thermo Fisher Scientific Inc.
  • Agilent Technologies Inc.
  • System Biosciences, LLC.
  • Jena Bioscience GmbH
  • Merck KGaA
  • Azenta Life Sciences (Genewiz)
  • Takara Bio Inc.
  • Synbio Technologies
  • Revvity Inc (Horizon Discovery Ltd.)
  • Synthego

Table Information

Report AttributeDetails
No. of Pages150
PublishedDecember 2025
Forecast Period2024 - 2033
Estimated Market Value ( USD ) in 2024 $ 579.5 Million
Forecasted Market Value ( USD ) by 2033 $ 2660 Million
Compound Annual Growth Rate18.6%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

gRNA - Global Strategic Business Report - Product Image

gRNA - Global Strategic Business Report

  • Report
  • 475 Pages
  • Global
From
Base Editing Market Size, Share & Trends Analysis Report by Products & Services (Platform, gRNA Design), by Application (Drug Discovery & Development), by Type, by End Use, by Region, and Segment Forecasts, 2025-2033 - Product Image

Base Editing Market Size, Share & Trends Analysis Report by Products & Services (Platform, gRNA Design), by Application (Drug Discovery & Development), by Type, by End Use, by Region, and Segment Forecasts, 2025-2033

  • Report
  • 120 Pages
  • Global
From
CRISPR Market by Offering [Product (Kits, Enzymes, Libraries), Service (gRNA Synthesis, Cell Line Development, Screening, Validation)], Application (Drug Discovery, Development, Agriculture) Competitive Landscape, Company Profiles -Global Forecast to 2030 - Product Image

CRISPR Market by Offering [Product (Kits, Enzymes, Libraries), Service (gRNA Synthesis, Cell Line Development, Screening, Validation)], Application (Drug Discovery, Development, Agriculture) Competitive Landscape, Company Profiles -Global Forecast to 2030

  • Report
  • 267 Pages
  • Global
From
CircRNA Synthesis Market Size, Share & Trends Analysis Report By Product & Service (Reagents & Kits), By Application (Therapeutics Development), By End-use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

CircRNA Synthesis Market Size, Share & Trends Analysis Report By Product & Service (Reagents & Kits), By Application (Therapeutics Development), By End-use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 120 Pages
  • Global
From
siRNA/miRNA Synthesis Service Market - Global Forecast 2025-2030 - Product Image

siRNA/miRNA Synthesis Service Market - Global Forecast 2025-2030

  • Report
  • 197 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.